Administrative Supplements to Promote Diversity in Research and Development Small Businesses SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
ID: 356387Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering administrative supplements aimed at enhancing diversity within the research and entrepreneurial workforce supported by Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants. This funding opportunity is designed to recruit, mentor, and support individuals from underrepresented backgrounds and those with disabilities, facilitating their involvement in ongoing research projects without leading independent clinical trials. The initiative emphasizes the importance of diverse perspectives in advancing health-related research and professional development, with eligible applicants including small businesses and various research candidates. Interested parties should note that the application deadline is October 13, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PA-24-255.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), announces funding opportunities for administrative supplements targeting enhanced diversity within research and entrepreneurial workforces supported by Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants. The purpose is to recruit, mentor, and support individuals from underrepresented backgrounds and those with disabilities, aiming to advance research training and professional development. This funding initiative allows applications to support candidates without leading independent clinical trials and encourages participation in research led by mentors. The program seeks to improve the overall impact of ongoing projects by incorporating various individuals' perspectives and experiences into the application process. Eligible participants include undergraduate students, degree holders, graduate students, postdoctoral scholars, and independent researchers, with specific guidance on budgetary constraints and submission protocols. Applicants must comply with NIH and CDC policies, ensuring inclusivity and adherence to project scopes. The program will evaluate applications based on the proposed experience's integration into existing research, the candidate's qualifications, and the demonstration of adequate mentorship.
    Similar Opportunities
    Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Supplements to Promote Diversity in Health-Related Research," aimed at enhancing diversity within the health research workforce. This initiative seeks to recruit and support individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and those from disadvantaged backgrounds, while providing necessary accommodations for researchers with disabilities. The funding, which can reach up to $500,000, is available for administrative supplements to existing research grants, with applications undergoing administrative review rather than peer review. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 7, 2026.
    Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Opportunities for New and 'At-Risk' Investigators to Promote Workforce Diversity," aimed at enhancing diversity within the biomedical research workforce. This initiative invites R01 grant applications for independent research projects that align with the scientific missions of participating NIH Institutes or Centers, specifically targeting New Investigators and At-Risk Investigators from underrepresented backgrounds, including racial and ethnic minorities and individuals with disabilities. The program underscores the significance of diverse perspectives in addressing health disparities and aims to strengthen the research pipeline while fostering innovative solutions to public health challenges. Interested applicants can find more information and guidelines at the NIH grants website, with applications due by November 5, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Small Business Technology Transfer (STTR) program, aimed at developing technologies to improve minority health and eliminate health disparities. Eligible applicants, specifically United States small business concerns (SBCs), are invited to submit grant applications for the R41/R42 program, which may include clinical trials, focusing on innovative solutions that are effective, affordable, and culturally acceptable for underserved populations. This initiative emphasizes the importance of addressing health inequities through technology, including disease self-management tools and mobile health solutions, with applications due by December 9, 2026. For further details, applicants can refer to the full announcement at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities," aimed at supporting U.S. small businesses in developing innovative technologies, products, or services that address health disparities among minority populations. Eligible applicants are encouraged to propose solutions that enhance healthcare delivery, promote health-seeking behaviors, and overcome barriers in minority health, with funding available through the Small Business Innovation Research (SBIR) program for both Phase I and II grants. This initiative underscores the government's commitment to advancing health equity and leveraging small business innovation to tackle significant healthcare challenges faced by underserved communities. Applications are due by December 10, 2026, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering a Small Business Innovation Research (SBIR) Grant opportunity for United States small business concerns (SBCs) to submit applications for various phases of research and development, including Phase I, Phase II, Direct to Phase II, Fast-Track, and Phase IIB grants. Eligible applicants must possess the necessary research capabilities and technological expertise to support the R&D missions of the NIH and CDC, with a focus on health-related innovations. This funding opportunity is significant as it encourages collaboration among small businesses to advance health research, with applications expected to be solicited following the reauthorization of the SBIR program. Interested parties can reach out to the NIH SEED Office at SEEDinfo@nih.gov or call 301-827-8595 for further information, with the estimated synopsis posting date set for October 1, 2025, and a closing date for applications anticipated on January 5, 2026.
    NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA), is inviting eligible United States small business concerns (SBCs) to prepare for the upcoming Small Business Innovation Research (SBIR) Grant opportunity, specifically under the Parent SBIR [R43/R44] Clinical Trial Not Allowed category. This funding opportunity aims to support innovative research and development projects that align with the missions of the NIH, CDC, and FDA, encouraging collaborations among small businesses with relevant technological expertise. While applications are not currently being solicited, potential applicants should note that the estimated synopsis post date is October 1, 2025, with a closing date of January 5, 2026, and an estimated award date of June 1, 2026. For further inquiries, interested parties can contact the NIH SEED Office at SEEDinfo@nih.gov or by phone at 301-827-8595.
    Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)" to support early-career scientists transitioning into entrepreneurship. This funding opportunity aims to facilitate the career development of investigators by providing grants that support research and development activities, alongside essential entrepreneurial training and mentorship. The program is specifically designed for U.S. small business concerns, with a focus on fostering innovation and enhancing public health, particularly from diverse and historically underrepresented groups. Interested applicants must submit their proposals by April 5, 2027, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Addressing Health Inequities in Clinical Diagnostics" under the Small Business Innovation Research (SBIR) program (R43/R44). This initiative invites Small Business Concerns (SBCs) to develop improved clinical diagnostics that address health disparities caused by existing clinical laboratory assays and point-of-care devices, particularly those that do not adequately consider diverse patient populations. The program aims to foster advancements that enhance health outcomes for historically underrepresented groups by encouraging applicants to identify specific disparities and propose innovative solutions. Applications will be accepted starting March 5, 2024, with a close date of January 5, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-158.html.
    Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Research With Activities Related to Diversity (ReWARD)" (PAR-23-122), aimed at enhancing diversity, equity, inclusion, and accessibility (DEIA) within the biomedical research workforce. This grant supports scientists who significantly contribute to DEIA and currently lack NIH research project funding, providing resources for both scientific research and ongoing DEIA activities aligned with the interests of participating NIH Institutes and Centers. The initiative is crucial for addressing underrepresentation in biomedical research and fostering innovative collaborations that promote inclusivity. Interested applicants, including higher education institutions and tribal governments, must submit a Diversity Statement and a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application, with the submission deadline set for May 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)," aimed at enhancing diversity within the biomedical research workforce. This funding opportunity supports early-career researchers from underrepresented backgrounds through a two-phase grant process: a mentored career development phase (K99) lasting up to two years, followed by a three-year independent research phase (R00), contingent on successful progress during the K99 phase. The initiative is critical for addressing health disparities by fostering diverse perspectives in biomedical research, with eligible applicants required to hold a clinical or research doctorate and be in postdoctoral training positions. Interested parties can find more information and apply through the NIH Grants website, with the application deadline set for September 7, 2027.